Publication | Open Access
Stem Cell Therapy for Perianal Crohn’s Disease
14
Citations
0
References
2018
Year
Combined cellular and anticytokine therapy of CD with perianal lesions significantly contributes to the more frequent and prolonged closure of simple fistulas, as compared to antibiotics/immunosuppressors, and to a decrease in the frequency of recurrence of the disease.